VIRO: ViroGates A/S - Summary | Jitta

ViroGates A/S

DNK:VIRO

Price
kr10.90
Loss Chance
54.1%
2.58JITTA SCORE
100.00%Over Jitta Line
Jitta Ranking
49 / 124
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (53)
Recent Business Performance (72)
Financial Strength (34)
Return to Shareholders (0)
Competitive Advantage (43)
Jitta Signs
Recent Business PerformanceEarning Growth Last Year
Revenue and EarningEarning loss detected in 2025
Operating MarginInconsistent
New Share IssuedMore than 50% in 5 years
CapExVery High
Key Stats
Jitta Score
Jitta Line
2.58
100.00%
4.95
38.73%
Health Care Equipment
5.91
46.61%
4.92
89.66%
6.11
48.08%
COMPANY DESCRIPTION
ViroGates A/S, an in vitro diagnostics company, develops and sells blood tests for measuring chronic inflammation for the healthcare sector. It offers suPARnostic TurbiLatex, a CE-IVD approved particle-enhanced turbidimetric immunoassay for quantitative measurement of suPAR in human plasma; suPARnostic AUTO Flex ELISA kit, a fully quantitative immunoassay designed for accurate and reliable measurement of soluble urokinase plasminogen activator receptor in human plasma; and suPARnostic Quick Triage, a test for rapid, quantitative measurement of suPAR levels. ViroGates A/S was founded in 2000 and is headquartered in Birkerød, Denmark.